drug · small molecule
BRIMONIDINE TARTRATE
pre_registrationupdated 3mo agoby Ocuvex Therapeutics Inc🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 8- drugCOMBIGAN51 co-mentions · 26 sources
- tagApproval46 co-mentions · 16 sources
- drugQOLIANA40 co-mentions · 19 sources
- drugLumify33 co-mentions · 26 sources
- drugbrimonidine26 co-mentions · 19 sources
- companyApotex Corp7 co-mentions · 3 sources
- tagRecall7 co-mentions · 7 sources
- drugBetimol3 co-mentions · 3 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 9 investigational indications.
targets
Adrenergic receptor alpha-2
all catalysts(0)
nothing on the calendar yet
Trials studying BRIMONIDINE TARTRATE
- phase2A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
- phase3Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution
- phase3Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
- phase3Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
- phase2TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis
- phase3"Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness"
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that